Search results for [Pharmaceutical industry.] at Tsuga Consortium

Results 11 to 18 of 18 | « previous

Pain hustlers : crime and punishment at an opioid startup / by Hughes, Evan,1975-author.;

Includes bibliographical references."The blistering inside story of a startup that made millions pushing opioids--until its cutthroat tactics were exposed and its executives put behind bars. John Kapoor had amassed a small fortune in pharmaceuticals when he conceived of a new product. It was the 2000s, and opioids were big business. If Kapoor, an immigrant and the billionaire founder of Insys, could find a new way to administer the highly potent fentanyl, he could patent his invention and sell it to those in need--at a steep price. The only problem: There weren't enough people in need. Kapoor's drug was approved for breakthrough cancer pain. If Subsys was going to turn a profit, the company would need to persuade doctors to prescribe it 'off-label,' for other, lesser forms of pain. This is the story of how Insys turned a niche drug into big business. With executives leading the charge, Insys sales reps seduced doctors with charm, money, and sex. Its administrators lied to health care providers, claiming recipients had cancer when they did not. It pushed drugs onto patients that would have benefited from safer options, or no drugs at all. The strategy worked: When Insys went public, it notched the biggest IPO of its year. But several employees reached their limit and quietly blew the whistle, bringing the full force of the justice system upon the drug maker. In [Pain Hustlers], author and National Magazine Award-finalist Evan Hughes lays bare the pharma playbook. He shows how drug makers like Insys, fueled by greed and a hunger for market share, turn deception into profit. The book represents a stunning vindication, but also a cautionary tale. As Hughes shows, Insys didn't do anything its competitors weren't also doing. It was simply worse at covering its tracks."--

Subjects: Insys Therapeutics, Inc.; Advertising; Opioid abuse; Pharmaceutical industry; Pharmaceutical industry; Opioids;

Available copies: 1 / Total copies: 1

unAPI

Unsettled : how the Purdue Pharma bankruptcy failed the victims of the American overdose crisis / by Hampton, Ryan,author.; Aron, Hillel,author.; Foster, Claire Rudy,author.;

A shocking inside account of reckless capitalism and injustice in the Purdue Pharma bankruptcy case. In September 2019, Purdue Pharma--the maker of OxyContin and a company controlled by the infamous billionaire Sackler family--filed for bankruptcy to protect itself from 2,600 lawsuits for its role in fueling the U.S. overdose crisis. Author and activist Ryan Hampton served as co-chair of the official creditors committee that acted as a watchdog during the process, one of only four victims appointed among representatives of big insurance companies, hospitals, and pharmacies. He entered the case believing that exposing the Sacklers and mobilizing against Purdue would be enough to right the scales of justice. But he soon learned that behind closed doors, justice had plenty of other competition-and it came with a hefty price tag. Unsettled is the inside story of Purdue's excruciating Chapter 11 bankruptcy proceedings, the company's eventual restructuring, and the Sackler family's evasion of any true accountability. It's also the untold story of how a group of determined ordinary people tried to see justice done against the odds-and in the face of brutal opposition from powerful institutions and even government representatives. Although America was envisioned as an equitable place, where the vulnerable are protected from the greed of the powerful, the corporate-bankruptcy process betrays those values. In its heart of hearts, this system is built to shield the ultra-wealthy, exploit loopholes for political power, promote gross wealth inequality, and allow companies such as Purdue Pharma to run amok. The real story of the Purdue bankruptcy wasn't that the billion-dollar corporation was a villain, a serial federal offender. No matter what the media said, Purdue didn't do this alone. They were aided and abetted by the very systems and institutions that were supposed to protect Americans. Even on-your-side elected officials worked against Purdue's victims-maintaining the status quo at all costs. Americans deserve to know exactly who is responsible for failing to protect people over profits-and what a human life is worth to corporations, billionaires, and lawmakers. Unsettled is what happened behind closed doors-the story of a sick, broken system that destroyed millions of lives and let the Sacklers off almost scot-free.

Subjects: Purdue Pharma L.P.; Bankruptcy; Opioid abuse; Pharmaceutical industry;

Available copies: 1 / Total copies: 1

unAPI

No More Tears : The Dark Secrets of Johnson & Johnson. by Harris, Gardiner.;

From award-winning investigative journalist Gardiner Harris comes an deeply reported expose of Johnson & Johnson, one of Americas oldest pharmaceutical companies. 'No More Tears' describes some of the largest, deadliest, and most expensive conspiracies of all time - their coverup of baby powder's linkage to cancer, the teen-directed marketing of the life-altering drug Risperdal, and more.Library Bound Incorporated

Subjects: BUSINESS & ECONOMICS / Corporate & Business History; BUSINESS & ECONOMICS / Industries / Pharmaceutical & Biotechnology; MEDICAL / Ethics;

Available copies: 0 / Total copies: 1

unAPI

The billionaire murders : the mysterious deaths of Barry and Honey Sherman / by Donovan, Kevin,1962-author.;

Billionaires, philanthropists, socialites ... victims. Barry and Honey Sherman appeared to lead charmed lives. But the world was shocked in late 2017 when their bodies were found in a bizarre tableau in their elegant Toronto home. First described as murder-suicide-- belts looped around their necks, they were found seated beside their basement swimming pool-- police later ruled it a staged, targeted double murder. Nothing about the case made sense to friends of the founder of one of the world's largest generic pharmaceutical firms and his wife, a powerhouse in Canada's charity world. Together, their wealth has been estimated at well over 4.7 billion dollars. There was another side to the story. A strategic genius who built a large generic drug company-- Apotex Inc.-- Barry Sherman was a self-described workaholic, renowned risk-taker, and disruptor during his fifty-year career. Regarded as a generous friend by many, Sherman was also feared by others. He was criticized for stifling academic freedom and using the courts to win at all costs. Upset with building issues at his mansion, he sued and recouped millions from tradespeople. At the time of his death, Sherman had just won a decades-old legal case involving four cousins who wanted 20 percent of his fortune. Toronto Star investigative journalist Kevin Donovan chronicles the unsettling story from the beginning, interviewing family members, friends, and colleagues, and sheds new light on the Shermans' lives and the disturbing double murder. Deeply researched and authoritative, The Billionaire Murders is a compulsively readable tale of a strange and perplexing crime.

Subjects: True crime stories.; Biographies.; Sherman, Barry, 1942-2017.; Sherman, Barry, 1942-2017; Sherman, Honey, 1948-2017.; Sherman, Honey, 1948-2017; Murder; Businesspeople; Pharmaceutical industry; Murder victims;

Available copies: 1 / Total copies: 1

unAPI

ADHD nation : children, doctors, big pharma, and the making of an American epidemic / by Schwarz, Alan,1968-author.;

Includes bibliographical references and index."A groundbreaking and definitive account of the widespread misdiagnosis of Attention Deficit Hyperactivity Disorder--and its serious effects on children, adults, and society. More than 1 in 7 American children are getting diagnosed with Attention Deficit Hyperactivity Disorder (ADHD)--three times what experts have said is appropriate--making it one of the most mishandled and debated conditions in medicine. The numbers are rising every year. Now doctors and Big Pharma are targeting adults and the rest of the world to get diagnosed with ADHD and take medications that will "transform their lives." In ADHD Nation, Alan Schwarz takes readers behind the scenes to show the roots and rise of this cultural and medical phenomenon: There's the father of ADHD, Dr.Keith Conners, who spends fifty years pioneering the disorder and use of drugs like Ritalin before realizing his role in what he now calls "a national disaster of dangerous proportions"; a troubled young girl and studious, teenaged boy who get entangledin the growing ADHD machine and take medications that cause them serious problems; and a pharmaceutical industry that egregiously overpromotes the disorder and earns billions from the mishandling of children (and now adults). While demonstrating that ADHD is real and can be successfully medicated, Schwarz sounds an alarm and urges America to wake up and address this growing national problem"--

Subjects: Attention-deficit hyperactivity disorder; Diagnostic errors;

Available copies: 0 / Total copies: 1

unAPI

Owning the sun : a people's history of monopoly medicine from aspirin to COVID-19 vaccines / by Zaitchik, Alexander,1974-author.;

Includes bibliographical references and index."Owning the Sun tells the story of one of the most contentious fights in human history: the legal right to control the production of lifesaving medicines. Medical science began as a discipline geared toward the betterment of all human life, but the merging of research with intellectual property and the rise of the pharmaceutical industry warped and eventually undermined its ethical foundations. Since the Second World War, federally funded research has facilitated most major medical breakthroughs, yet these drugs are often wholly controlled by price-gouging corporations with growing international ambitions. Why does the U.S. government fund the development of medical science in the name of the public, only to relinquish exclusive rights to drug companies, and how does such a system impoverish us, weaken our responses to global crises, and, as in the case of AIDS and COVID-19, put the world at risk? Outlining how generations of public health and science advocates have attempted to hold the line against Big Pharma and their allies in government, Alexander Zaitchik's first-in-kind history documents the rise of medical monopoly in the United States and its subsequent globalization. From the controversial arrival of patent-wielding German drug firms in the late nineteenth century, to present-day coordination between industry and philanthropic organizations-including the influential Gates Foundation-that stymie international efforts to vaccinate the world against COVID-19, Owning the Sun tells one of the most important and least understood histories of our time"--

Subjects: Medical care, Cost of; Medicine;

Available copies: 1 / Total copies: 1

unAPI

Mastering AI : a survival guide to our superpowered future / by Kahn, Jeremy,author.;

Includes bibliographical references (pages 253-312) and index.A Fortune magazine journalist draws on his expertise and extensive contacts among the companies and scientists at the forefront of artificial intelligence to offer dramatic predictions of AI's impact over the next decade, from reshaping our economy and the way we work, learn, and create to unknitting our social fabric, jeopardizing our democracy, and fundamentally altering the way we think. Within the next five years, Jeremy Kahn predicts, AI will disrupt almost every industry and enterprise, with vastly increased efficiency and productivity. It will restructure the workforce, making AI copilots a must for every knowledge worker. It will revamp education, meaning children around the world can have personal, portable tutors. It will revolutionize health care, making individualized, targeted pharmaceuticals more affordable. It will compel us to reimagine how we make art, compose music, and write and publish books. The potential of generative AI to extend our skills, talents, and creativity as humans is undeniably exciting and promising. But while this new technology has a bright future, it also casts a dark and fearful shadow. AI will provoke pervasive, disruptive, potentially devastating knock-on effects. Leveraging his unrivaled access to the leaders, scientists, futurists, and others who are making AI a reality, Kahn will argue that if not carefully designed and vigilantly regulated AI will deepen income inequality, depressing wages while imposing winner-take-all markets across much of the economy. AI risks undermining democracy, as truth is overtaken by misinformation, racial bias, and harmful stereotypes. Continuing a process begun by the internet, AI will rewire our brains, likely inhibiting our ability to think critically, to remember, and even to get along with one another -- unless we all take decisive action to prevent this from happening.

Subjects: Artificial intelligence.; Artificial intelligence; Artificial intelligence; Artificial intelligence;

Available copies: 1 / Total copies: 1

unAPI

In the blood : how two outsiders solved a centuries-old medical mystery and took on the US Army / by Barber, Charles,1962-author.;

Includes bibliographical references and index."The incredible true story of how an absent-minded inventor and a down-on-his-luck salesman joined forces to create a once in a generation lifesaving product--and were persecuted for it by the U.S. Army. At the 1993 Battle of Mogadishu, dramatized by the popular film Black Hawk Down, the majority of soldiers who died bled to death before they could even reach an operating table. This tragedy reinforced the need for a revolutionary treatment that could transform trauma medicine. So, when Frank Hursey and Bart Gullong--who had no medical or military experience--discovered that a cheap, crushed rock called zeolite had blood clotting properties, they brought it to the military's attention. The Marines and the Navy adopted the resulting product, QuikClot, immediately. The Army, however, resisted. It had two products of its own being developed to prevent excessive bleeds, one of which had already cost eighty million dollars. The other, "Factor Seven," had a more dangerous complication: its side effects could be deadly. Unwilling to let its efforts end in failure--and led by the highly influential surgeon Major John Holcomb--the Army set out to smear the reputations of the inventors whose product, they claimed, had its own risk. Over the course of six years, Hursey and Gullong engaged in an epic struggle with Holcomb for recognition--until a whistle blower inside the Army exposed Holcomb's financial ties to the pharmaceutical company that produced Factor Seven, a discovery that led to a massive lawsuit filed by the U.S. Department of Justice. By withholding QuikClot--which would later become the medical miracle of the Iraq War--and using Factor Seven with its known, life threatening risks, Holcomb imperiled countless American lives. Using deep reportage and riveting prose, In the Blood recounts this little known David and Goliath story of corruption, greed, and power within the military--and the devastating, fatal consequences of unchecked institutional arrogance"--

Subjects: Biographies.; Personal narratives.; Gullong, Bart.; Hursey, Frank.; Hemorrhage; Medicine, Military; Surgical dressings; Wound treatment equipment industry;

Available copies: 1 / Total copies: 1

unAPI

Results 11 to 18 of 18 | « previous